Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Roberto Castellucci
Abiraterone Acetate for Early Stage Metastatic Prostate Cancer: Patient Selection and Special Considerations
Therapeutics and Clinical Risk Management
Related publications
Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction
JAMA Oncology
Cancer Research
Oncology
A Phase 2 Trial of Abiraterone Acetate Without Glucocorticoids for Men With Metastatic Castration-Resistant Prostate Cancer
Cancer
Cancer Research
Oncology
Remarkable Response to Abiraterone Acetate in Castration-Resistant Prostate Cancer Patient With Aggressive Liver Metastasis
IJU Case Reports
Mp50-20 Impact of Abiraterone Acetate in Prostate Specific Antigen Trial Update: Effect of Abiraterone Acetate and Low Dose Prednisone on Prostate-Specific Antigen and Radiographic Disease Progression in Patients With Non-Metastatic Castration-Resistant Prostate Cancer
Journal of Urology
Urology
A Prognostic Model for Stratifying Clinical Outcomes in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate
Canadian Urological Association Journal
Urology
Clinical Evaluation of Abiraterone in the Treatment of Metastatic Prostate Cancer
Clinical Medicine Insights: Urology
Prostate-Specific Antigen Decline After 4 Weeks of Treatment With Abiraterone Acetate and Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer
European Urology
Urology
Colorectal Endoscopic Submucosal Dissection: Patient Selection and Special Considerations
Clinical and Experimental Gastroenterology
Gastroenterology
Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New Onset Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Molecular Cancer Therapeutics
Cancer Research
Oncology
